Chemoprofiling as Breeding Tool for Pharmaceutical Use of Salix by Förster, Nadja et al.
fpls-12-579820 March 26, 2021 Time: 17:39 # 1
ORIGINAL RESEARCH

















This article was submitted to
Plant Metabolism
and Chemodiversity,
a section of the journal
Frontiers in Plant Science
Received: 03 July 2020
Accepted: 08 March 2021
Published: 01 April 2021
Citation:
Förster N, Antoniadou K,
Zander M, Baur S,
Mittermeier-Kleßinger VK, Dawid C,
Ulrichs C and Mewis I (2021)
Chemoprofiling as Breeding Tool
for Pharmaceutical Use of Salix.
Front. Plant Sci. 12:579820.
doi: 10.3389/fpls.2021.579820
Chemoprofiling as Breeding Tool for
Pharmaceutical Use of Salix
Nadja Förster1* , Kyriaki Antoniadou2, Matthias Zander1, Sebastian Baur2,
Verena Karolin Mittermeier-Kleßinger2, Corinna Dawid2,3, Christian Ulrichs1 and
Inga Mewis1
1 Division Urban Plant Ecophysiology, Humboldt-Universität zu Berlin, Berlin, Germany, 2 Chair of Food Chemistry
and Molecular Sensory Science, Technical University of Munich, Freising, Germany, 3 Bavarian Center for Biomolecular Mass
Spectrometry, Technical University of Munich, Freising, Germany
Willow bark is traditionally used for pharmaceutical purposes. Evaluation is so far
based on the salicylate content, however, health promoting effects of extracts might be
attributed to the interaction of those salicylates with other compounds, which support
and complement their action. So far, only S. purpurea, S. daphnoides, and S. fragilis are
included in pharmaceutical extracts. Crossing with other species could result in a more
diverse secondary metabolite profile with higher pharmacological value. With the help
of targeted inter- and intraspecific crossing, new chemotypes were generated, whereby
nine different Salix genotypes (S. alba, S. daphnoides, S. humboldtiana, S. lasiandra, S.
nigra, S. pentandra, S. purpurea, S. x rubens, S. viminalis) were included in the study.
Based on substances known for their health promoting potential and characteristic for
Salix (selected phenolic compounds including salicylates), a targeted metabolomics
analysis and clustering of 92 generated Salix clones was performed revealing four
different cluster/chemoprofiles. In more specific, one group is formed by S. daphnoides
clones and inter- and intraspecific hybrids, a second group by S. viminalis clones and
inter- and intraspecific hybrids, a third group generally formed by S. alba, S. pentandra,
S. x rubens, and S. lasiandra clones and hybrids, and a fourth group by S. purpurea
clones and inter- and intraspecific hybrids. Clustering on the basis of the selected
phenolic compounds can be used for identifying Salix clones with a different compound
profile. New combinations of secondary plant metabolites offer the chance to identify
Salix crosses with improved effects on human health.
Keywords: chemoprofiling, clustering, phenolics, salicylates, Salix crosses, willow
INTRODUCTION
Bark of Salix spp. is used for pharmaceutical purposes to treat headaches as well as fever, rheumatic
diseases, arthritis, and relieve low back pain. These anti-inflammatory and anti-oxidative effects
were attributed mostly to specific bark compounds, the salicylates, which have been identified
in selected Salix species (Meier et al., 1987; Kammerer et al., 2005). Therefore, herbal remedies
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were obtained from Salix species, which contain minimum 1.5%
total salicylic derivatives as, for example, postulated for Salix
purpurea, Salix daphnoides, and Salix fragilis (ESCOP, 2017).
To treat low back pain and mild rheumatic conditions, ESCOP
recommends a daily oral dose of up to 240 mg equivalent
salicin/day (salicylates hydrolyzed to salicin). Using Salicis cortex
for treating arthritis and rheumatism is widespread accepted and
analyzed intensively as reviewed in Sulima and Przyborowski
(2019). For example, according to an open, multicentric
observational study with reference treatment where patients were
treated with a standardized willow bark extract, results show that
using the willow bark extract was comparable in effectiveness
to standard therapies for treating mild or fairly severe cases of
gonarthrosis and coxarthrosis (Beer and Wegener, 2008).
Additionally to the salicylates, identified as biological markers
for activity, other groups of secondary plant metabolites are
known in the bark of willows, like e.g., flavonoids, flavan-
3-ols, and oligomeric procyanidins (Shao, 1991; Jürgenliemk
et al., 2007; Förster et al., 2008). Salix species can differ
widely in their secondary plant metabolite profiles. Additionally,
current studies have clearly shown that bioactive effects of bark
extracts cannot be exclusively traced back to the salicylates.
Other bark compounds can support and complement their
action. Further, other identified compounds are also of relevance
(Schmid et al., 2001; Khayyal et al., 2003, 2005; Lardos et al.,
2004; Nahrstedt et al., 2007; Ishikado et al., 2013; Enayat and
Banerjee, 2014). Khayyal et al. (2003), for instance, analyzed
the effect of willow bark extract and different fractions in
comparison to acetylsalicylic acid (ASS) on edema in the rat
paw. The extract and ASS inhibit the edema in the same degree.
Analysis of the single fractions show that additionally to the
salicin containing fractions, fractions containing polyphenols
were active and show anti-inflammatory effects. Nahrstedt et al.
(2007) analyzed five different extract fractions (A–E; A: mainly
unidentified polyphenols, B: unidentified polyphenols and
flavonoids, C: flavonoids, D: salicin, and E: proanthocyanidins)
in in vitro and in vivo studies and identified efficacies of
willow bark extract fractions are mediated by polyphenols, like
proanthocyanidins and flavonoids, as well. In in vitro studies
of Ishikado et al. (2013) it was found that the activation of
the ARE promoter, proven for willow bark extracts, was not
mediated by salicin or its metabolites. Salicin free extracts
showed an activation and thus an induction of antioxidative
enzymes and prevention from oxidative stress via activation
of Nrf2. Additionally, in comparison to single compounds,
synergetic effects of different compounds in the bark are
conceivable (Nahrstedt et al., 2007; Enayat et al., 2013) and
well-known for drugs produced from natural products (Liu,
2003; Ulrich-Merzenich et al., 2010). Durak and Gawlik-Dziki
(2014) described synergistic effects of active compounds in coffee
and willow, known as valuable sources for chlorogenic acid
and salicin derivates, respectively. Due to the point that both
substances are known to be present in high contents in specific
Salix species, the presumption of synergism is strengthened.
Also, synergistic effects of flavonoids and phenolic acids were
determined (Hajimehdipoor et al., 2014), both compound classes
are known for Salix.
Considering the background of an aging population
along with increasing numbers of age-related diseases like
rheumatism, arthritis, etc., targeted Salix crosses, which show
new combinations of diverse secondary plant metabolites, can be
used to produce bioactive willow bark extracts with an improved
medicinal potential. According to the European Union herbal
monograph on Salix (EMA/HMPC/80630/2016) the species
S. purpurea, S. daphnoides, and S. fragilis are allowed to be
included in pharmaceutical extracts. Other species might be
of interest for usage in the future. For example, in the bark
of Salix pentandra high contents of 2‘-O-Acetylsalicortin, an
acetylated form of salicortin, is present (Förster, 2010). Analysis
of acetylated and non-acetylated glucosinolates of Moringa
oleifera showed that the acetyl group can have a decisive role
promoting biological activity (Förster et al., 2016). Piatczak
et al. (2020) examined a strong anti-oxidative activity of Salix
alba bark extracts, a willow species with no or less contents of
salicylic acids. Additionally to their differing bark compound
profile, shrub willow is an energy crop and is known to be fast-
growing and high-yielding. Many studies have highlighted the
complex, multigenic basis for heterosis in inbred crops (Carlson,
2018). Hybridization of Salix is used to generate crosses with
higher biomass yield and growth. A targeted creation of Salix
crosses with a diverse compound profile was not in focus
of work until now.
The aim of the study was to perform targeted crossing of
Salix species to generate different chemotypes. Next to two
species named in the monograph (S. purpurea, S. daphnoides),
seven more Salix genotypes were included: Salix alba, Salix
humboldtiana, Salix lasiandra, Salix nigra, Salix pentandra, Salix
x rubens, Salix viminalis. Salix species were chosen based on a
diverse bark chemical profile as well as the possibility to generate
vital crosses. With the help of targeted inter- and intraspecific
crossing, 64 new Salix crosses were generated. Based on known
bioactive compound groups in the Salix bark as well as single
characteristic metabolites in the selected willow species, all
Salix species and crosses were divided into different clusters.
This targeted approach was performed to confirm bioactivity
according to pharmaceutical standards. Next to salicylates, there
exists a general knowledge about possible health promoting
effects of phenolic compounds also known for Salix bark as
reviewed for example for flavonoids (Panche et al., 2016),
proanthocyanidins (Cires et al., 2017), and phenolic acids such
as chlorogenic acid and caffeic acid (Sato et al., 2011; Naveed
et al., 2018). The presence of dissimilar groups of flavonoids
may change the type of a pharmacological activity in the bark,
from the increase of antioxidant effect (Evans, 2000). For
isosalipurposide, in an in vivo assay of two-stage carcinogenesis
on mouse skin a delayed formation of papillomas was found
(Yagura et al., 2008). Additionally, the authors postulated
anti-proliferative and anti-carcinogenic activity. Chalcones
(isosalipurposid and its derivatives) and flavanones (naringenin
and its glucosides) are known to enhance spasmolytic and
anti-inflammatory activity (Bandgar et al., 2012; Letafat et al.,
2013). For catechin and epicatechin a lot of pharmacological
effects like anti-oxidative, anti-carcinogenic, or cardioprotective
effects were reported (Ganeshpurkar and Saluja, 2020). Due
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to the point of characteristic/specific compounds for Salix
(in general and in single species) as well as known health
promoting potential of single ingredients as well, the following
secondary plant compounds were included in the targeted
approach: flavan-3-ols (catechin and epicatechin), flavonoids
(eriodictyol-7-O-glucoside, two isomers of naringenin-5-O-
glucoside, naringenin-7-O-glucoside, luteolin-7-O-glucoside,
quercetin-hexoside, isosalipurposide, and ampelopsin),
salicylates (salicin, salicortin, 2‘-O-acetylsalicortin, 2‘-O-
acetylsalicin, and tremulacin), other phenolic compounds
(triandrin, two caffeic acid derivatives, two purpurein isomers,
salireposide, and syrengin). Goal of the study was to identify
new Salix crosses with diverse compound profiles, which could
provide the basis for willow extracts with an improved value
on human health. These (optimized) extracts could be used as
alternative to non-steroidal anti-inflammatory drugs (NSAIDs)
for treating joint and spine related inflammatory pain—as herbal
remedies are often better tolerated and have less side effects
(Maroon et al., 2010).
MATERIALS AND METHODS
Chemicals
The following compounds used for preparing extracts by
targeted analysis of phenolic compounds and eluents were
obtained commercially: resorcinol (Fluka, Germany), methanol
(HPLC grade, VWR BDH Chemicals, Poole, United Kingdom),
tetrahydrofuran (HPLC grade, VWR BDH Chemicals, Poole,
United Kingdom), formic acid (Merck KGaA, Darmstadt,
Germany), and orthophosphoric acid (85%, VWR BDH
Chemicals, Poole, United Kingdom). Water used for extract and
eluent preparation was purified by a Milli-Q Integral 10 system
(Millipore, MA, United States).
Collection of Salix Species
Hardwood cuttings from the following Salix species originated in
Germany, Poland, Austria, Sweden, Romania, Hungary, United
Kingdom, and the United States were collected between 2006
and 2009: Salix alba, Salix daphnoides, Salix humboldtiana, Salix
lasiandra, Salix nigra, Salix pentandra, Salix purpurea, Salix
x rubens, Salix viminalis (Supplementary Table). Clones were
established and cultivated at Humboldt-Universität zu Berlin
(exceptions see Supplementary Table). Parental forms were
planted in 2012 and crosses in 2015 (for VI3_h, VI6, HU1, and
SN1 not known). To include crossable species with a diverse
compound profile in the crossing experiment, in pre-tests the
profile of selected phenolics in the Salix bark (see targeted
analysis) was analyzed (Shao, 1991; Förster, 2010; Köhler, 2016;
Bubner et al., 2018).
Inter- and Intraspecific Salix Crosses
Crosses were generated from matured stock collections from the
different Salix species whereby branches of males were cut in
spring. After flowering, the pollen was collected and stored at
4◦C. Catkins of females were bagged before flowering and directly
pollinated on the plant or were pollinated in crossing chambers
with a sterile brush. The ripened capsules are used as seeds for
further cultivation.
Propagation and Cultivation of Salix
Species and Crosses
Collected cuttings from Salix species were inserted and further
cultivated on open field areas in Berlin or Zepernick, Germany
(6–9 cuttings per species). Seeds from new generated Salix crosses
were sown in pots and cultivated in the greenhouse for a few
weeks until they were transferred to the open field areas in
Berlin or Zepernick. too. Only viable seedlings with a vigorous
growth were selected for planting in the open field areas. From
each seedling hardwood cuttings were generated to have 6–9
cloned single plants for each genotype. Based on the vitality
of the seedlings from the different crossing combinations 1–12
descendants were planted. The planting pattern was 300 cm
between and 50 cm within the rows. Between different clones a
distance of 150 cm was used. Besides an annual pruning back to
the trunk, plants were watered at severe drought and mulched to
reduce weed pressure.
To analyze inter- as well intraspecific differences in the
compound profile of Salix bark, 92 clones mostly cultivated in
Berlin or Zepernick, Germany (parental and filial generation)
were included in the study (Supplementary Table). Bark
material of willow species which were not yet in focus of our
work was harvested in collections of the Thünen-Institute in
Waldsieversdorf, Germany, Wriezen, Germany, or in Garzau,
Germany (Supplementary Table).
For the chemical analysis of bark material 1-year-old branches
of the Salix plants were cut off in August 2016. Due to the point
that clone variability was not in focus of the present work, from
each genotype (species and crosses) a composite sample from
bark material of 3–5 plants generated from the hardwood cuttings
from each mother plant was used. Bark from the branches was
peeled at a height from 10 to 100 cm, frozen (−80◦C), and
immediately lyophilized.
Targeted Analysis to Determine Phenolic
Compounds in the Salix Bark
For the extraction of phenolics a method described by Förster
et al. (2008) was used. Briefly, 50 mg pulverized bark material
was extracted with 750 µL 80% methanol and 100 µl resorcinol
(50 mM, internal standard) in an ultrasonic bath with ice
water for 10 min. After centrifugation (6,000 rpm, 5 min, 4◦C)
the supernatant was collected and the pellet was re-extracted
with 500 µL of the extraction solution twice. The combined
supernatants were concentrated in a vacuum concentrator to
near dryness and refilled with ultrapure water up to 1 mL. The
extract was filtered using SpinX tubes (0.22 µm) and stored
at −20◦C until HPLC analysis. The HPLC system consisted of
a DIONEX P680 pump, an ASI-100 auto sampler, a TCC-100
thermally regulated column department and an UltiMate 3000
Photodiode Array Detector. The software Chromeleon 6.8 was
used for peak evaluation. Reversed phase chromatography was
carried out on an Acclaim PolarAdvantage C16 column (3 µm,
120 Å, 2.1 × 150 mm, Thermo Fisher Scientific) protected
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by a pre-column (5 µm, 120 Å, 2 × 10 mm, Thermo
Fisher Scientific). Eluents used for HPLC analysis were (A) 2%
tetrahydrofuran, 0.5% phosphoric acid in ultrapure water and
(B) 100% methanol. The extracts were analyzed with a flow
rate of 0.35 mL/min and the following gradient program: 0% B
(0–5 min), 0–15% B (5–10 min), 15–25% B (10–20 min), 25–35%
B (20–30 min), 35–50% B (30–40 min), 100% B (40–42 min),
100–0% B (42–44 min), and 0% (44–49 min) injecting each
sample two times (technical replicates). Injection volume was
10 µL and peak detection was carried out at 270 nm. Phenolics
were quantified against internal standard resorcinol (50 mM,
Fluka). Commercially available or isolated standards of single
compounds were used as reference. Response factors (RF) in
relation to the internal standard resorcinol were used to correct
for absorbance difference (RF salicin: 1.73, RF salicortin: 0.34, RF
2′-O-acetylsalicortin: 2.98, RF tremulacin: 4.53, RF eriodictyol-
7-O-glucoside: 0.16, RF naringenin-7-O-glucoside: 0.27, RF
luteolin-7-O-glucoside: 0.07, RF ampelopsin: 0.22, RF catechin:
0.34, RF epicatechin: 0.86, RF syrengin: 0.23). If a standard was
not available, RF of a compound with a similar chemical structure
was used (2′-O-acetylsalicin: RF as 2′-O-acetylsalicortin 2.98,
naringenin-5-O-glucoside I+ II: RF as naringenin-7-O-glucoside
0.27, quercetin-hexoside: RF as isoquercitrin 0.08, triandrin
and purpurein I + II: RF as coumaric acid 0.17, caffeic acid
derivatives: RF as caffeic acid 0.27) or set as 1 (isosalipurposide,
salireposide). Qualitative analysis and identification of phenolics
was based on their retention times, specific UV-spectra (Shao,
1991) and mass spectrometry (characteristic mass fragment ions
by HPLC-DAD-ESI-MS3, [M-H]−). The phenolic content was
calculated in mg/g dry weight (DW).
Cluster Analysis of Salix Analyzed by the
Targeted Approach
Grouping analysis of quantitative compound data was done
by SPSS Statistics Version 24 using the Ward’s method with
Euclidean distance as a hierarchical clustering method. Based
on the formed dendrogram, four clusters were used to describe
the dataset best.
RESULTS
To determine the content of the selected phenolic compounds
in the Salix bark, a targeted metabolomic analysis was
performed. The following phenolic compounds were
identified and quantified: five salicylates (salicin, salicortin,
2‘-O-acetylsalicortin, 2′-O-acetylsalicin, and tremulacin),
eight flavonoids (eriodictyol-7-O-glucoside, two isomers of
naringenin-5-O-glucoside, naringenin-7-O-glucoside, luteolin-
7-O-glucoside, quercetin-hexoside, isosalipurposide, and
ampelopsin), two flavan-3-ols (catechin and epicatechin),
and seven other phenolic compounds (triandrin, two caffeic
acid derivatives, two purpurein isomers, salireposide, and
syrengin). The different Salix species and crosses differ in
their profile of detected phenolic compounds (Tables 1–4).
Total phenolic contents vary between 1.70 (VI6, Table 2) and
42.31 mg/g DW (DA2, Table 1). S. daphnoides, S. purpurea, and
S. pentandra clones show generally highest phenolic contents
(f. e. DA5 17.77 mg/g DW, PU2 26.30 mg/g DW, Table 1;
PE1 38.79 mg/g DW, Table 2), and S. alba and S. viminalis
lowest (VI4 3.97 mg/g DW, Table 2; AL5 2.59 mg/g DW,
Table 3). Whereas, S. daphnoides clones showed high contents
of salicylates, especially salicortin (e.g., DA2 with 11.77 mg/g
DW), no salicylates could be found in S. viminalis (except
VI1). S. pentrandra clones contained high contents of 2′-
O-acetylsalicortin (e.g., PE1 with 33.22 mg/g DW). S. alba,
S. lasiandra, and S. humboltiana showed just low salicylate
contents (salicin, 2′-O-acetylsalicortin). While, S. viminalis
was characterized by high contents of triandrin (e.g., VI3_h
with 10.37 mg/g DW), S. purpurea contained high levels of
total flavonoids and other phenolic compounds like purpurein
and salireposide.
Based on the clustering analysis (grouping of phenolic
compounds found by targeted analysis) all investigated Salix
clones (parent species and crosses) can be divided in four general
compound clusters: cluster 1 (S. daphnoides including selected
crosses of S. daphnoides with S. viminalis and S. purpurea),
cluster 2 (S. viminalis, S. humboldtiana, S. nigra including selected
crosses of S. viminalis with S. daphnoides and S. nigra with
S. pentandra), cluster 3 (S. pentandra, S. alba, S. x rubens,
S. lasiandra and crosses of these species, as well as HU1 ×
PU1_2, VI1 × DA1_9, VI6, and PU4 × VI2 crosses), cluster
4 (S. purpurea clones including selected crosses of S. purpurea
with S. daphnoides or VI3_h, HU1 × PU1 and crosses with
S. daphnoides, and HU1× PU1_1,3). Clones belonging to cluster
1 generally had comparatively high contents of salicylates and
other phenolic compounds such caffeic acid derivatives and
syrengin, naringenin-5-O-glucoside as well as high contents of
catechins (Table 1). Clones of cluster 2 were characterized by
very high contents of the phenolic compound triandrin and high
contents of the flavonoid ampelopsin (Table 2). Clones of cluster
3 were characterized by very high contents of the salicylates
2′-O-acetylsalicortin and 2′-O-acetylsalicin, but also flavonoids,
catechins, and other phenolic compounds such as triandrin and
salireposide (Table 3). Clones of cluster 4 showed high contents
of the salicylates salicin, salicortin, and tremulacin as well as
catechins and had also very high contents of flavonoids such as
naringenin-7-O-glucoside and isosalipurposide (Table 4).
DISCUSSION
Based on the targeted metabolomics approach, inter- and
intraspecific crosses of Salix species showed mostly an
intermediate total secondary plant metabolite content of
their parents (Tables 1–4). Focusing on single compounds,
S. daphnoides has high levels of salicortin and tremulacin, which
is missing in S. viminalis. The obtained crosses contained these
compounds (for example VI1 × DA1, Table 2). According
to this, the crosses clustered similar to their parental forms
[exceptions: VI1×DA1_9, PU4×VI2_1-2, HU1× PU1_2, PU3
× DA6_1-5 (HU1 × PU1) × DA4_1-3]. This is in accordance
to former analysis of Orians et al. (2000) who detected that two
phenolic glycosides in the leaves of hybrids of Salix eriocephala
and Salix sericea, salicortin and 2′-cinnamoylsalicortin, had
intermediate contents. However, the authors found high
variations in compound contents for hybrids but on average

















TABLE 1 | Phenolic compound profile of clones of S. viminalis, S. daphnoides, and their crosses.
Phenolic compounds (mg/g DW)






















































































































































2.87 3.37 3.98 0.05 0.81 1.00 0.89 0.06 0.03 1.13 0.87 0.09 0.50 0.07 1.31 17.02 1
S. viminalis (VI2) 0.38 0.67 4.74 0.23 6.02 2
Crosses
1 1.26 3.53 6.86 0.05 0.86 0.71 1.40 0.20 0.03 1.08 0.78 0.40 0.52 17.68 1
2 2.37 8.08 11.87 0.11 1.34 1.59 2.18 0.09 0.03 1.71 1.35 0.66 1.17 0.37 0.70 33.62 1
3 1.98 7.33 8.01 0.33 1.52 2.13 3.30 0.07 2.83 1.73 0.83 0.53 0.56 0.69 31.84 1
4 0.93 2.83 5.15 0.04 0.31 0.48 0.42 0.08 0.04 0.79 0.66 0.90 0.76 0.38 13.77 1
5 1.68 5.10 4.18 0.10 1.18 1.41 1.35 0.17 0.05 1.39 1.27 1.05 0.93 0.78 0.60 21.23 1
S. daphnoides
(DA2)
2.42 11.77 11.10 1.37 1.86 2.21 2.69 0.10 0.03 5.17 1.26 0.56 0.60 0.72 0.45 42.31 1
S. daphnoides
(DA3)
0.89 1.51 3.45 0.12 0.90 1.15 1.63 0.04 0.05 1.15 0.54 1.09 1.14 2.12 15.78 1
Crosses
1 1.45 6.28 9.34 0.15 0.88 1.04 1.72 0.02 0.02 1.96 1.58 0.59 0.52 0.76 0.74 27.05 1
2 1.69 7.14 7.63 0.13 1.16 1.65 1.42 0.04 0.02 2.52 1.39 0.65 0.65 0.68 0.73 27.50 1
3 1.41 5.03 3.30 0.17 1.07 1.43 1.42 0.05 1.69 1.31 0.29 0.35 0.35 0.56 18.43 1
4 1.35 4.08 9.51 0.05 0.48 0.59 0.72 0.06 0.02 0.80 0.91 0.51 0.60 0.66 20.35 1
5 1.85 7.35 8.59 0.15 1.36 1.93 1.41 0.04 0.02 3.03 1.76 0.43 0.55 0.54 0.58 29.59 1
6 1.29 0.55 7.97 0.03 0.65 0.72 1.12 0.03 0.02 1.05 1.11 0.55 0.46 0.66 16.21 1
7 1.63 4.52 7.80 0.07 1.14 1.48 1.10 0.07 0.01 1.49 1.67 0.29 0.28 0.52 0.69 22.76 1
8 1.84 7.75 6.97 0.17 1.86 2.18 2.29 0.07 0.01 3.79 1.90 0.57 0.57 0.66 0.94 31.57 1
S. daphnoides
(DA5)
2.50 7.39 6.38 0.07 1.51 2.42 0.75 0.03 0.05 2.59 1.44 0.78 0.92 0.94 27.77 1
S. purpurea (PU2) 1.01 3.54 8.09 0.45 2.44 2.12 0.46 0.28 0.22 1.37 0.11 3.58 0.07 2.12 0.44 26.30 4
Crosses
1 2.92 6.95 3.09 0.22 1.77 2.80 0.76 0.02 0.14 2.91 1.56 0.77 0.51 0.10 1.06 25.58 1
2 2.41 4.07 5.82 0.11 0.80 1.14 1.02 0.04 0.11 0.58 1.87 0.88 1.00 0.04 1.47 21.37 1



































TABLE 2 | Phenolic compound profile of clones of S. viminalis, S. daphnoides, S. purpurea, S. humboldtiana, S. nigra, S. pentandra, and their crosses.
Phenolic compounds (mg/g DW)








































































































































































S. viminalis (VI1) 0.47 0.02 0.09 0.89 8.82 4.49 14.78 2
S. daphnoides (DA1) 2.24 6.40 11.36 0.03 1.31 1.92 1.39 0.08 0.04 2.36 1.50 1.04 1.05 1.12 1.28 33.12 1
Crosses
1 1.03 3.18 6.75 0.08 0.75 1.13 1.70 0.11 0.17 1.29 1.99 0.84 0.77 1.12 1.10 3.04 25.05 1
2 0.03 0.32 0.46 4.03 0.29 5.13 2
3 0.04 0.07 0.65 0.70 3.82 0.43 5.71 2
4 0.05 0.05 0.44 0.82 7.14 0.27 8.77 2
5 0.10 0.04 0.52 0.81 3.27 0.57 5.31 2
6 0.07 0.04 0.73 0.92 5.81 0.43 8.00 2
7 0.03 0.18 0.55 3.64 0.25 4.65 2
8 0.24 0.03 0.34 0.53 2.16 0.26 3.56 2
9 0.78 1.37 0.03 0.26 0.26 0.58 0.03 0.06 1.42 2.81 0.08 0.97 8.65 3
S. purpurea (PU4) 0.74 1.90 1.84 0.79 1.12 1.32 0.23 0.13 0.03 0.96 0.09 2.32 0.10 1.41 0.56 13.54 4
S. viminalis (VI2) 0.38 0.67 4.74 0.23 6.02 2
Crosses
1 0.38 0.67 0.08 0.50 0.48 0.10 0.01 0.34 0.26 2.02 3.94 1.20 0.12 10.10 3
2 0.27 0.04 0.43 0.54 0.09 0.02 0.02 0.16 0.33 1.11 1.70 0.56 0.28 5.55 3
S. humboldthiana
(HU1)
0.69 0.01 0.33 0.40 0.09 1.47 1.24 2.98 0.26 0.65 8.12 2
S. viminalis (VI6) 0.29 0.03 0.13 0.85 0.01 0.39 1.70 3
Crosses
1 0.81 0.01 0.27 0.34 0.02 0.10 1.06 5.19 0.35 8.15 3
2 0.50 0.01 0.52 0.76 0.05 0.20 0.68 3.99 0.35 7.06 3
S. nigra (SN1) 0.02 0.25 0.88 3.02 0.29 4.46 2
S. pentandra (PE1) 0.16 33.22 4.38 0.03 0.41 0.25 0.34 38.79 3
Crosses
1 1.17 0.03 0.21 0.97 8.07 0.23 10.68 2
S. viminalis (VI4) 0.03 0.46 0.55 2.86 0.07 3.97 2
S. viminalis (schwerinii × viminalis) (VI3_h*) 0.46 0.78 10.37 0.36 11.97 2
Crosses
1 0.33 0.32 6.09 0.13 6.87 2
2 0.06 0.42 0.51 9.42 0.23 10.64 2
S. viminalis (VI5) 0.20 0.64 8.36 0.14 9.34 2
S. viminalis (VI2) 0.38 0.67 4.74 0.23 6.02 2
Crosses
1 0.75 0.43 4.03 0.23 5.44 2
2 0.37 5.75 0.17 6.29 2
3 0.34 0.89 6.12 0.19 7.54 2
4 0.37 0.53 4.11 0.15 5.16 2



































TABLE 3 | Phenolic compound profile of clones of S. alba, S. x rubens, S. purpurea, S. humboldtiana, S. lasiandra, S. pentandra, and their crosses.
Phenolic compounds (mg/g DW)

















































































































































































0.69 0.01 0.33 0.40 0.09 1.47 1.24 2.98 0.26 0.65 8.12 2
S. purpurea (PU1) 1.27 11.41 17.25 0.10 3.01 1.61 0.29 0.10 0.06 1.10 3.39 0.05 0.11 1.14 0.36 41.25 4
Crosses
1 0.32 0.17 0.87 0.03 1.05 1.44 0.03 0.57 0.06 2.71 0.23 0.76 0.25 8.49 4
2 2.31 1.19 0.01 0.26 0.43 0.09 1.83 0.18 6.30 3
3 1.23 1.42 0.03 1.00 1.38 0.18 0.04 0.09 0.49 2.43 0.76 0.82 0.24 10.11 4
S. alba (AL2) 0.41 0.97 0.19 0.47 0.73 0.41 0.46 0.30 0.45 4.39 3
S. x rubens (AL1_h) 2.80 1.66 0.10 0.30 1.04 0.40 0.52 0.23 0.34 7.39 3
Crosses
1 0.96 0.10 0.17 1.29 0.45 0.09 0.68 0.25 3.99 3
2 0.55 1.55 0.05 0.12 1.06 0.12 0.56 0.21 4.22 3
S. alba (AL2) 0.41 0.97 0.19 0.47 0.73 0.41 0.46 0.30 0.45 4.39 3
S. pentandra (PE1) 0.16 33.22 4.38 0.03 0.41 0.25 0.34 38.79 3
Crosses
1 0.99 26.09 5.58 0.16 0.24 0.48 0.25 0.68 34.47 3
2 1.15 18.08 1.21 0.24 0.63 0.74 0.51 0.25 0.62 23.43 3
S. pentandra (PE2) 0.27 14.92 1.35 0.33 1.39 0.23 0.14 0.13 18.76 3
S. lasiandra (LA1) 0.72 2.11 0.08 0.41 1.32 0.60 0.25 0.65 6.13 3
Crosses
1 0.62 13.92 0.43 1.41 0.17 0.55 0.40 17.50 3
2 1.27 0.49 1.18 0.42 0.22 3.58 3
3 3.57 0.23 0.87 0.06 0.27 0.27 5.27 3
S. pentandra (PE2) 0.27 14.92 1.35 0.33 1.39 0.23 0.14 0.13 18.76 3
S. alba (AL5) 0.26 0.07 0.92 0.72 0.35 0.27 2.59 3
Crosses
1 1.01 10.03 0.19 1.91 1.25 0.51 0.21 15.11 3
2 2.93 4.15 3.07 0.35 2.86 1.72 0.30 0.26 15.64 3
3 0.93 19.45 2.87 0.10 1.42 0.06 0.26 0.19 25.28 3
4 0.22 9.92 0.53 1.50 0.42 0.36 0.31 13.26 3
S. alba (AL3) 1.12 1.12 0.11 1.49 0.34 0.56 0.38 5.12 3
S. alba (AL4) 0.13 0.91 0.57 0.39 0.32 0.52 2.84 3
Crosses
1 1.35 1.16 0.08 1.48 0.58 0.68 0.35 5.68 3
2 1.39 0.18 1.69 0.61 0.57 0.21 4.65 3



































TABLE 4 | Phenolic compound profile of clones of S. daphnoides, S. viminalis, S. purpurea, S. humboldtiana × S. purpurea, and their crosses.
Phenolic compounds (mg/g DW)






































































































































































S. purpurea (PU3) 2.39 2.61 1.62 2.42 3.64 0.07 0.09 0.14 1.66 1.47 0.12 0.15 3.50 0.98 20.86 4
S. daphnoides
(DA6)
1.58 3.42 2.58 0.04 1.13 1.33 1.06 0.02 0.90 1.70 0.47 0.52 0.61 0.83 16.18 1
Crosses
1 0.93 2.17 0.06 1.28 1.62 0.46 0.16 0.23 0.72 1.64 0.10 0.05 0.48 0.99 10.89 4
2 2.04 5.21 4.54 0.03 1.09 1.38 0.55 0.20 0.15 0.87 2.87 0.42 0.02 0.57 1.40 21.35 4
3 1.52 4.13 4.70 0.02 0.87 1.06 0.33 0.11 0.17 0.68 1.60 0.26 0.02 1.15 0.66 17.28 4
4 1.25 4.18 6.30 0.08 1.05 1.58 0.40 0.07 0.12 0.80 2.73 0.32 0.09 0.01 1.36 0.84 21.18 4
5 0.98 3.32 1.45 0.02 0.95 1.32 0.37 0.03 0.07 0.75 2.15 0.28 0.12 0.05 0.56 0.49 12.91 4
S. purpurea (PU3) 2.39 2.61 1.62 2.42 3.64 0.07 0.09 0.14 1.66 1.47 0.12 0.15 3.50 0.98 20.86 4
S. purpurea (PU2) 1.01 3.54 8.09 0.45 2.44 2.12 0.46 0.28 0.22 1.37 0.11 3.58 0.07 2.12 0.44 26.30 4
Crosses
1 0.69 3.99 10.30 0.14 1.37 1.91 0.18 0.17 0.17 1.09 0.10 2.45 2.58 0.70 25.84 4
2 0.92 2.95 6.76 0.25 2.13 2.77 0.38 0.19 0.19 1.66 0.20 2.53 0.05 1.74 0.50 23.22 4




0.82 0.02 1.40 1.97 0.07 0.05 3.06 0.33 0.07 0.28 1.27 0.47 9.81 4
S. daphnoides
(DA4)
1.45 4.98 3.45 0.10 1.36 1.66 2.07 0.04 0.03 2.95 1.62 0.95 1.14 0.99 1.71 24.50 1
Crosses
1 0.43 1.85 0.52 0.15 1.54 2.21 0.64 0.06 0.02 2.06 1.64 0.24 0.20 0.05 0.48 12.09 4
2 0.50 1.76 0.10 0.89 1.22 0.31 0.07 0.03 0.95 1.63 0.15 0.17 0.04 0.51 8.33 4
3 1.20 3.19 1.49 0.06 1.53 2.17 0.34 0.08 0.07 0.93 1.83 0.23 0.12 0.78 14.02 4




0.46 0.78 10.37 0.36 11.97 2
Crosses
1 0.97 0.18 3.12 1.60 0.02 0.60 0.83 0.03 0.11 0.40 0.21 1.60 3.84 0.13 0.11 0.08 0.90 0.63 15.37 4
2 0.67 5.54 5.01 0.01 0.59 0.73 0.18 0.47 0.29 1.56 2.44 0.14 0.23 1.46 0.43 19.75 4
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lower than the midpoint of the parental taxa. Orians et al. (2000)
concluded an incomplete dominance in inheritance of phenolic
glycosides and therefore, more included alleles that control
the production of these compounds. Moreover, Hallgren et al.
(2003) found intermediate contents of condensed tannins and
phenolic glucosides in hybrids of Salix caprea and Salix repens
in comparison to the parental generation. In some cases, crosses
show lower compound contents, for example identified for
quercetin-hexoside in DA2 × DA3 (Table 1) or for salicin in
most crosses of VI1×DA1 (Table 2). Higher compound contents
could be observed for example for salicortin or tremulacin in
(DA2 × DA3) × VI2, Table 1. These results could be traced
back to a heterosis effects (over-dominance) as identified for
condensed tannins in eucalypt hybrids (O’Reilly-Wapstra et al.,
2014). Nevertheless, tending reasons could be differences in
plant age and therefore a different shoot amount and rootstock
development, but also diverse environmental conditions on the
growth locations or variable season of harvest of Salix species
(Förster et al., 2008). Other inheritance pattern like dominance
or co-dominance (similar contents to one or both parental
taxa) and under-expression (lower contents in hybrids) are also
common for secondary plant metabolites (Cheng et al., 2011).
For instance, this can be observed for VI1 × DA1 (Table 2)
where the metabolite profile of cross 1 is comparable to the
profile of DA1, whereas the crosses 2–8 were similar to VI1. The
results obtained are in accordance with Rieseberg and Ellstrand
(1993), who showed that 68% of the chemicals produced by the
parents can be found in hybrids. Additionally, hybrids can lack
in specific secondary plant metabolites (deficiency) or can show
novel compounds which cannot be identified in the parental
generation (Orians, 2000). Focusing on the quality and not on
the quantity of plant compounds, according to the author, 5%
of the chemicals identified in the parental generation are new
in hybrids and 27% of chemicals get lost. These findings are in
accordance with our results showing that 22% of the analyzed
phenolics which were identified in at least one of the parents
could not be detected in the Salix crosses. If both parents show
the metabolite, just 2% get lost in the filial generation. In case
of the identified compounds in the present study, we found, for
example, that the analyzed crosses of AL3 and AL4 do not show
triandrin, whereas in both parents triandrin could be identified
(Table 3). In crosses of AL2 and PE1, ampelopsin was detected
as a novel compound, which was not detected in the parental
generation. New compounds in hybrids, which were not detected
in the parental generation, could be hardly recognized in Salix.
Therefore, we can assume that most chemical compounds were
inherited dominantly with Mendelian laws. However, it has been
postulated that male Salix plants were affected less severe by
fungal pathogens (Melampsora spp.) in comparison to females
(Moritz et al., 2016). Apparently, plant characteristics can be
inherited gender-dependent. A different vulnerability of female
and male Salix clones to fungal diseases could be explained
by a different secondary plant metabolite profile even if other
authors could not identify such a relationship (Hakulinen, 1998;
Hakulinen and Julkunen-Tiitto, 2000). In our study, the analyzed
crosses of the filial generation did not differ clearly between male
and female descendants in their secondary metabolite pattern.
Additionally, it was not observed that one parent has generally
more influence on the metabolite pattern of the Salix crosses in
the filial generation.
Important to keep in mind is that the profile of secondary
plant metabolites is not only genetically specific, it can also
be influenced by biotic as well as abiotic factors like pest
infestations and environmental conditions (e.g., temperature,
soil). It is therefore not surprising that selected Salix clones
should be cultivated under controlled conditions to form a
stable and safe source of bark with high quality for medical
uses (Sulima and Przyborowski, 2019). In our study, it was not
possible to grow all 92 Salix genotypes in one site. Therefore,
clones were not cultivated under controlled conditions, but
under similar environmental conditions in Berlin/Brandenburg,
Germany. Sulima et al. (2017) analyzed bark extracts from 91
genotypes of S. purpurea and identified a high variation in the
content of salicylates between genotypes. In own investigations a
high intraspecific variability of bark phenolics of Salix cultivated
in the same site was identified, too (Förster, 2010). Therefore,
it seems to be advisable to control the cultivation conditions
strongly. Due to the amount of 92 different clones (and therefore
approximately 800 plants) included in this study, it was not
possible to grow all Salix clones at one side. To minimize the
influence of this factor for the present study, nearly all clones
analyzed were cultivated at two sites, in Berlin or Zepernick.
Additionally, for the standardization of willow bark extracts,
which is absolutely necessary for the production of efficient
bark extract, specific components should be analyzed to evaluate
therapeutic properties (Sulima and Przyborowski, 2019).
Crosses were generated to obtain descendants, which
perform better than their parents (heterosis effect). For Salix,
targeted crossing (interspecific hybridization) is used to generate
genotypes with a higher yield and biomass production due to
their use as energy crop as well as plants with an increased
vigor, pest and disease resistance. Hybridization plays therefore
a key role to obtain improved genotypes which can be used as
bioenergy crop (Carlson, 2018). Additionally, generating intra-
and interspecific crosses of Salix offer the chance to generate
genotypes with new combinations of secondary plant metabolites
in the bark. Analysis of heterosis for vitamins and antioxidant
pigments in cauliflower showed a positive direction for ascorbic
acid, anthocyanin, and lycopene concentration and a negative
direction for carotenoids and chlorophyll pigments (Dey et al.,
2014). Therefore, hybrids show different contents of vitamins and
antioxidant plant pigments. Analysis with grape hybrids showed
a substantial positive mid-parent and better-parent heterosis for
anthocyanins and total flavonoids, whereas a negative mid-parent
heterosis and heterobeltiosis was found for total phenolics (Sahoo
et al., 2017). Based on these findings from literature as well as
our results of the analysis of targeted compounds in the Salix
bark, it is possible to generate Salix crosses with a different profile
of distinct secondary plant compounds. Due to diverse health
promoting effects of the compounds as well as possible synergetic
effects, a different bioactivity of generated bark extracts is
obvious. To define possible pharmaceutical effects, it is needed to
evaluate the quantity of phenolic acids, flavan-3-ols, flavonoids,
salicylates, and other phenolic compounds specific for Salix
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species and link it to bioactivity in bioassays, which is currently
ongoing in our collaborative project.
Based on chemoprofiling of the Salix clones of parent species
and crosses performed by use of the targeted approach, genotypes
could be grouped into different clusters with similar compound
profiles. Mostly, crosses show a similar phenolic compound
profile as their parents (same cluster as both or one parent; two
exceptions: PU4 × VI2_1-2, Table 2; HU1 × PU1_2, Table 3).
However, targeted crossing resulted in hybrids from species
with different chemical profiles (descendants in different cluster,
VI1 × DA1, Table 2; HU1 × PU1, Table 3). Based on the
Mendelian laws mixed compound profiles have been obtained.
In further breeding approaches, the focus should be set on the
enhancement of single compounds with most health promoting
effects or specific compound combinations. Due to the fact
that there are other potent bioactive compounds in the Salix
bark (f. e. Nahrstedt et al., 2007) except salicylates, the full
therapeutic potential of Salicis cortex can be reached through
a targeted selection of clones used for extract production. The
compound profile in the bark is strongly species dependent
and can vary in inter- and intraspecific crosses qualitatively
and quantitatively. Generating different chemoprofiles, and
therefore new combinations of secondary plant metabolites,
offer the chance to identify Salix crosses with improved effects
on human health.
The presented study included the qualitative and quantitative
analysis of possible literature-known bioactive compounds (Salix
characteristic and known for their health promoting potential) in
a targeted metabolomics approach and is a very useful starting
point for crossing experiments. The results form one important
factor for clustering different chemotypes of Salix. As other
bioactive substances may be present in willow bark and could be
a second important factor for breeding strategies, an untargeted
approach was performed (Supplementary Information). In sum,
five groups (four main groups and one group just consisting
of one clone) could be visualized via PCA analysis of the
untargeted metabolomics data (Supplementary Figure). Cluster
and groups identified by the targeted (Tables 1–4) and untargeted
approach (Supplementary Figure) have been very similar with
many overlaps. Those cluster/groups are very good starting
points for genotype selection to perform bioactivity assays. Bark
extracts of selected clones from the four cluster/groups as well as
fractions thereof were analyzed in bioactivity assays; results will
be published elsewhere. To identify further unknown potential
bioactives in the Salix bark, an activity guided fractionation is
currently in progress. The combination of an untargeted and a
targeted metabolomics approach presents a valuable opportunity
for a rapid fingerprint of different plants, extracts, or species as
postulated for Rosmarinus officinalis by Maldini et al. (2016).
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